Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.

Martín SF, Navarro F, Forthoffer N, Navas P, Villalba JM.

J Bioenerg Biomembr. 2001 Apr;33(2):143-53.

PMID:
11456220
2.

Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg(2+)-dependent enzyme and role of isoprenoid chain.

Martín SF, Gómez-Díaz C, Navas P, Villalba JM.

Biochem Biophys Res Commun. 2002 Sep 27;297(3):581-6.

PMID:
12270134
3.

Inhibition of neutral Mg2+-dependent sphingomyelinase by ubiquinol-mediated plasma membrane electron transport.

Martín SF, Gómez-Díaz C, Bello RI, Navas P, Villalba JM.

Protoplasma. 2003 May;221(1-2):109-16.

PMID:
12768348
4.

Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.

Bernardo K, Krut O, Wiegmann K, Kreder D, Micheli M, Schäfer R, Sickman A, Schmidt WE, Schröder JM, Meyer HE, Sandhoff K, Krönke M.

J Biol Chem. 2000 Mar 17;275(11):7641-7.

5.

The subcellular localization of neutral sphingomyelinase in rat liver.

Hostetler KY, Yazaki PJ.

J Lipid Res. 1979 May;20(4):456-63.

6.

Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells.

Navas P, Fernandez-Ayala DM, Martin SF, Lopez-Lluch G, De Caboa R, Rodriguez-Aguilera JC, Villalba JM.

Free Radic Res. 2002 Apr;36(4):369-74.

PMID:
12069099
7.
8.

Identification of three competitive inhibitors for membrane-associated, Mg2+-dependent and neutral 60 kDa sphingomyelinase activity.

Kim SK, Jung SM, Ahn KH, Jeon HJ, Lee DH, Jung KM, Jung SY, Kim DK.

Arch Pharm Res. 2005 Aug;28(8):923-9.

PMID:
16178418
9.

A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species.

Fensome AC, Rodrigues-Lima F, Josephs M, Paterson HF, Katan M.

J Biol Chem. 2000 Jan 14;275(2):1128-36.

10.

Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.

Kölzer M, Arenz C, Ferlinz K, Werth N, Schulze H, Klingenstein R, Sandhoff K.

Biol Chem. 2003 Sep;384(9):1293-8.

PMID:
14515991
11.

Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine.

Tamiya-Koizumi K, Kojima K.

J Biochem. 1986 Jun;99(6):1803-6.

12.

Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.

Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK.

J Biol Chem. 2002 Oct 25;277(43):41128-39.

13.

Identification and evaluation of neutral sphingomyelinase 2 inhibitors.

Lee DH, Kim SH, Ahn KH, Kim SK, Choi JM, Ji JE, Won JH, Park YH, Lim C, Kim S, Kim DK.

Arch Pharm Res. 2011 Feb;34(2):229-36. doi: 10.1007/s12272-011-0208-y.

PMID:
21380806
14.
15.

Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle.

Zheng T, Li W, Wang J, Altura BT, Altura BM.

Eur J Pharmacol. 2000 Mar 10;391(1-2):127-35.

PMID:
10720644
17.

Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione.

Liu B, Hannun YA.

J Biol Chem. 1997 Jun 27;272(26):16281-7.

18.

Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3.

Takeda Y, Tashima M, Takahashi A, Uchiyama T, Okazaki T.

J Biol Chem. 1999 Apr 9;274(15):10654-60.

19.
20.

Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies.

Chatterjee S, Ghosh N.

J Biol Chem. 1989 Jul 25;264(21):12554-61. Erratum in: J Biol Chem 1990 Jan 15;265(2):1231.

Items per page

Supplemental Content

Support Center